Crosspoint leads $56m Series B round for ReversingLabs

Crosspoint Capital Partners has led a $56 million Series B round for ReversingLabs, a provider of technology to protect software producers and enterprise software buyers against the threat of software supply chain attacks.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this